[Lung diseases due to atypical mycobacteria].
The epidemiology, symptoms, diagnosis, and treatment of mycobacterioses are reviewed. In the Canton of Vaud, Switzerland, the incidence of mycobacterioses approximates to 1% of infectious tuberculosis cases. Non-pathogenic typical mycobacteria have been identified in 2.8% of non-infectious chronic respiratory disorders, in 1.2% after culture conversion of respiratory tuberculosis, and mixed with tubercle bacilli in 4% of cases.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004352:Drug Resistance, Microbial; D006801:Humans; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000382:microbiology*; D012882:Skin Tests; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents
Pneumopathies à mycobactéries atypiques